stockhead15h
Health Check: Paradigm receives FDA guidance on proposed trial for dodgy knees
Paradigm Biopharmaceuticals says the FDA has endorsed key elements of its proposed phase III knee osteoarthritis trial.
FierceBiotech20h
Drug based on anti-nausea agent reduces Alzheimer's-advancing astrocytes in mice, biotech says
Much of the brain is made up of a constellation of star-shaped cells called astrocytes, which play vital roles in immunity, ...
Prediction: This Will Be the First Healthcare Stock to Join the Trillion-Dollar Club
Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the ...
GlobalData on MSN1d
Darmiyan introduces Alzheimer’s testing platform with BrainSee test
The BrainSee test avoids traditional Alzheimer's assessments that rely on general biomarkers such as amyloid or tau.
Zacks.com on MSN1d
Lilly Gets FDA Approval for Eczema Drug Ebglyss
Eli Lilly and Company LLY announced that the FDA has granted approval to its IL-13 inhibitor Ebglyss (lebrikizumab) for ...
Daily Montanan2d
Why millions are trying FDA-authorized alternatives to weight loss drugs
Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself “at my ideal ...
Alzheimer’s disease could be slowed by boosting a certain protein in the brain, researchers say
Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...
Bristol-Myers Squibb’s KarXT Faces FDA Approval Hurdles: Analyst Issues Sell Rating Amid Labeling Concerns
Morgan Stanley analyst Terence Flynn has maintained their bearish stance on BMY stock, giving a Sell rating on September 3. Terence Flynn has ...
NBC264d
FDA approves new Alzheimer's drug to slow disease progression
The FDA has approved a groundbreaking new drug to slow the progression of Alzheimer's disease in its early stages, offering ...
Kearney Hub4d
'This is why we walk': New drug that may slow Alzheimers now offered in Kearney area
Kearney physician Dr. Bradley Rodgers will soon offer Kisunla, the first drug proven to slow the early onset of Alzheimer’s.
Study finds Alzheimer's drugs might boost healthy protein in brain
Researchers have discovered that Alzheimer's drugs Leqembi and Kisunla boost levels of a healthy form of protein in the brain, even as they reduce its more toxic form.
San Francisco Examiner6d
Alzheimer's Drugs May Work in Whole New Way, Study Finds
THURSDAY, Sept. 11, 2024 (HealthDay News) -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab ...